Total Payments
$8,532
2024 Payments
$1,861
Companies
24
Transactions
479
Medicare Patients
1,056
Medicare Billing
$118,042
Payment Breakdown by Category
Food & Beverage$8,092 (94.8%)
Education$405.10 (4.7%)
Gifts$34.58 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,092 | 470 | 94.8% |
| Education | $405.10 | 7 | 4.7% |
| Gift | $34.58 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,303 | 131 | $0 (2024) |
| Janssen Biotech, Inc. | $1,023 | 39 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $939.46 | 65 | $0 (2024) |
| Celgene Corporation | $886.35 | 89 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $695.58 | 42 | $0 (2024) |
| QOL Medical, LLC | $413.77 | 24 | $0 (2024) |
| GENZYME CORPORATION | $365.73 | 13 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $362.46 | 19 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $317.69 | 3 | $0 (2023) |
| PFIZER INC. | $265.10 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,861 | 104 | ABBVIE INC. ($610.17) |
| 2023 | $1,795 | 94 | Celgene Corporation ($350.63) |
| 2022 | $1,758 | 121 | ABBVIE INC. ($434.17) |
| 2021 | $2,331 | 123 | AbbVie Inc. ($694.05) |
| 2020 | $500.83 | 34 | AbbVie Inc. ($274.17) |
| 2019 | $99.00 | 1 | Janssen Biotech, Inc. ($99.00) |
| 2017 | $186.95 | 2 | Janssen Biotech, Inc. ($186.95) |
All Payment Transactions
479 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: LIVER DISEASE | ||||||
| 12/16/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.83 | General |
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $34.69 | General |
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| Category: GI | ||||||
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 323 | 339 | $237,519 | $34,769 |
| 2022 | 10 | 333 | 359 | $267,875 | $36,922 |
| 2021 | 10 | 400 | 420 | $294,967 | $46,351 |
Total Patients
1,056
Total Services
1,118
Medicare Billing
$118,042
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 87 | 89 | $86,400 | $9,477 | 11.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 36 | 37 | $45,200 | $6,698 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 48 | $14,517 | $4,789 | 33.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 46 | 46 | $36,800 | $3,454 | 9.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 54 | $16,127 | $3,368 | 20.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $22,000 | $2,422 | 11.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $5,600 | $1,920 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,500 | $1,583 | 35.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $6,375 | $1,059 | 16.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 79 | 81 | $97,200 | $7,414 | 7.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 38 | 41 | $57,400 | $7,371 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 44 | $13,200 | $4,147 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 58 | $16,400 | $3,824 | 23.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 26 | 27 | $27,000 | $3,125 | 11.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 40 | 40 | $32,000 | $3,053 | 9.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 16 | $6,400 | $2,490 | 38.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,775 | $1,942 | 33.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $7,950 | $1,864 | 23.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $4,550 | $1,693 | 37.2% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 93 | 95 | $114,000 | $11,013 | 9.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 35 | 35 | $49,000 | $6,400 | 13.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 65 | $19,500 | $6,362 | 32.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 50 | 50 | $15,000 | $6,091 | 40.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 62 | 62 | $49,600 | $4,302 | 8.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 20 | $8,000 | $3,171 | 39.6% |
About Dr. Rahul Kataria, M.D
Dr. Rahul Kataria, M.D is a Gastroenterology healthcare provider based in Lansdowne, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1538401831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rahul Kataria, M.D has received a total of $8,532 in payments from pharmaceutical and medical device companies, with $1,861 received in 2024. These payments were reported across 479 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($8,092).
As a Medicare-enrolled provider, Kataria has provided services to 1,056 Medicare beneficiaries, totaling 1,118 services with total Medicare billing of $118,042. Data is available for 3 years (2021–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Lansdowne, VA
- Active Since 03/25/2013
- Last Updated 02/05/2026
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1538401831
Products in Payments
- ZEPOSIA (Drug) $1,183
- XIFAXAN (Drug) $741.67
- HUMIRA (Biological) $733.58
- STELARA (Biological) $724.57
- RINVOQ (Biological) $454.22
- ENTYVIO (Biological) $401.33
- DUPIXENT (Biological) $365.73
- ZENPEP (Drug) $362.46
- SKYRIZI (Biological) $336.62
- REMICADE (Biological) $311.54
- LINZESS (Drug) $272.17
- SUCRAID (Drug) $267.42
- XELJANZ (Drug) $247.45
- GATTEX (Drug) $213.07
- TRULANCE (Drug) $197.79
- MAVYRET (Drug) $166.01
- CREON (Drug) $157.91
- Sucraid (Drug) $146.35
- INJECTAFER (Drug) $125.00
- SUTAB (Drug) $118.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lansdowne
Satinder Gill, Md, MD
Gastroenterology — Payments: $23,429
Gastroenterology $23,429
Dr. Hani Sabahi, M.d, M.D
Gastroenterology — Payments: $17,357
Gastroenterology $17,357
Sanjeev Wasan, Md, MD
Gastroenterology — Payments: $7,365
Gastroenterology $7,365
Hiwot Desta, Md, MD
Gastroenterology — Payments: $4,812
Gastroenterology $4,812
Juan De La Ossa, Do, DO
Gastroenterology — Payments: $999.84
Gastroenterology $999.84